Cork, Michael J., Benjamin Lockshin, Andreas Pinter, Zhen Chen, Brad Shumel, and Randy Prescilla. “Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis Who Did Not Achieve Clear or Almost Clear Skin According to the Investigator’s Global Assessment: A Post Hoc Analysis of a Phase 3 Trial”. Acta Dermato-Venereologica 104 (February 12, 2024): adv13467. Accessed October 2, 2024. https://medicaljournalssweden.se/actadv/article/view/13467.